We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Htetf (MM) | NASDAQ:HTRN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.84 | 0 | 01:00:00 |
The full report is available at: www.microstockprofit.com/ads/HTRN
HealthTronics Inc. (HTRN) provides healthcare services and manufactures medical devices, primarily for the urology community. The Company provides lithotripsy services, which is a medical procedure where a device called a lithotripter transmits high-energy shockwaves through the body to break up kidney stones. Its lithotripsy services are provided principally through limited partnerships and other entities that it manages, which use lithotripters. During the year ended December 31, 2009, physicians who are affiliated with the Company used its lithotripters to perform approximately 50,000 procedures in the United States. HTRN has two types of contracts, retail and wholesale, that it enters into in providing its lithotripsy services. Retail contracts are agreements where it contracts with the hospital and private insurance payors. Wholesale contracts are agreements where it contracts only with the hospital.
Message Board Search for HTRN: http://www.boardcentral.com/boards/HTRN
In the report, the analyst notes:
"Revenue from continuing operations for the fourth quarter of 2009 totaled $50.3 million, up from $44.6 million in the fourth quarter of 2008. The Company's net loss for the fourth quarter of 2009, in accordance with generally accepted accounting principles ("GAAP"), totaled $2.3 million or $0.05 per diluted share.
"HTRN, a leading provider of urological products and services, recently announced that it has signed a definitive merger agreement with Endo Pharmaceuticals pursuant to which Endo will acquire HTRN. Under the terms of the merger agreement, Endo will commence an all cash tender offer to acquire all of the outstanding shares of HTRN common stock for approximately $223 million or $4.85 cash per HTRN share plus the assumption of debt. The transaction has been approved by the boards of directors of both companies."
To read the entire report visit: www.microstockprofit.com/ads/HTRN
See what investors are saying about HTRN at penny stock forum
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.
CONTACT: MicroStockProfit.comBrian Johnson
1-888-307-2850
info@microstockprofit.com
1 Year Htetf (MM) Chart |
1 Month Htetf (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions